BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hyperion Therapeutics 

601 Gateway Boulevard
Suite 200
San Francisco  California  94080  U.S.A.
Phone: 650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


SEARCH JOBS










 Company News
Hyperion Therapeutics Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Application For RAVICTI® 6/26/2014 7:38:51 AM
Hyperion Therapeutics To Present At The JMP Healthcare Conference 6/19/2014 8:32:43 AM
Hyperion Therapeutics To Present At 2014 Wells Fargo Healthcare Conference 6/13/2014 7:56:10 AM
Hyperion Therapeutics Completes Acquisition Of Andromeda Biotech 6/12/2014 7:20:13 AM
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI® New Drug Submission With Priority Review 6/3/2014 9:16:56 AM
Hyperion Therapeutics To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 9:36:13 AM
Hyperion Therapeutics To Present At Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/8/2014 10:41:52 AM
Hyperion Therapeutics Announces First Quarter 2014 Financial Results 5/7/2014 9:03:45 AM
Hyperion Therapeutics To Report First Quarter 2014 Financial Results After Market On May 6, 2014 4/30/2014 9:10:13 AM
Hyperion Therapeutics Wagers Up To $570 Million On Andromeda Biotech To Beef Up Orphan Disease Pipeline 4/24/2014 9:03:36 AM
123456789